Eculizumab treatment for renal failure in a pediatric patient with COVID-19

Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?

(2020) Courtney M. Campbell et al.   CIRCULATION

Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology

(2020) Daniel Batlle et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Acute kidney injury in patients hospitalized with COVID-19

(2020) Jamie S. Hirsch et al.   KIDNEY INTERNATIONAL

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

(2020) Cynthia Magro et al.   Translational Research

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City

(2020) Eva W. Cheung et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

The renaissance of complement therapeutics

(2017) Daniel Ricklin et al.   Nature Reviews Nephrology

Eculizumab in secondary atypical haemolytic uraemic syndrome

(2017) Teresa Cavero et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome

(2013) Ágnes Szilágyi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION